Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical and Translational Gastroenterology (CTG)Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease

Long-term outcomes of lifestyle interventions to promote weight maintenance — the current first-line management for patients with NAFLD — are often unsatisfactory. DTx can overcome the drawbacks of traditional lifestyle treatments through telecare medical services. At the same time, implementing DTx introduces a different level of self-management motivation for patients, greatly improving the treatment adherence and therapeutic effect among NAFLD patients.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form